- Home
- NSIT vs GRFS Comparison
NSIT vs GRFS Comparison
Compare NSIT & GRFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NSIT | GRFS |
|---|---|---|
| Founded | 1988 | 1940 |
| Country | United States | Spain |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.1B | 5.2B |
| IPO Year | 1996 | 2008 |
Fundamental Metrics
Financial Performance| Metric | NSIT | GRFS |
|---|---|---|
| Price | $170.00 | $8.87 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 4 | 2 |
| Target Price | ★ $177.50 | $10.37 |
| AVG Volume (30 Days) | 368.9K | ★ 735.9K |
| Earning Date | 11-05-2026 | 07-28-2022 |
| Dividend Yield | N/A | ★ 3.13% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 4.28 | N/A |
| Revenue | ★ $8,247,180,000.00 | N/A |
| Revenue This Year | $12.22 | $1.89 |
| Revenue Next Year | $4.75 | $6.20 |
| P/E Ratio | $39.68 | ★ $18.67 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $63.62 | $6.96 |
| 52 Week High | $182.12 | $9.77 |
Technical Indicators
Market Signals| Indicator | NSIT | GRFS |
|---|---|---|
| Relative Strength Index (RSI) | 54.31 | 75.79 |
| Support Level | $150.96 | $7.18 |
| Resistance Level | $179.73 | $9.77 |
| Average True Range (ATR) | 8.77 | 0.27 |
| MACD | -0.96 | 0.07 |
| Stochastic Oscillator | 67.10 | 99.63 |
Price Performance
Historical ComparisonAbout NSIT Insight Enterprises Inc.
Insight Enterprises Inc is a Fortune IT provider engaged in helping businesses of all sizes, large enterprises, government agencies, schools, and healthcare organizations. The company has three geographic operating segments: North America, EMEA, and APAC. It generates maximum revenue from the North America segment. The company provides digital workplace, cloud/data center transformation, IT modernization, Cyber Security and supply chain optimization solutions and services.
About GRFS Grifols S.A.
Grifols SA is a healthcare company engaged in activities related to plasma-derived products and diagnostic solutions. The group has four reportable segments: Biopharma, Diagnostic, Bio Supplies, and Others. The Biopharma segment focuses on products derived from human plasma for therapeutic use, while the Diagnostic segment includes the marketing of diagnostic testing equipment and reagents. The Bio Supplies segment covers biological products for non-therapeutic use and plasma sales to third parties, and the Others segment includes manufacturing services, research activities, and complementary pharmaceutical products.